Navigation Links
Celsion Announces ThermoDox's Prominence in Abstracts Presented at the 2nd International MR-Guided Ultrasound Symposium
Date:10/19/2010

COLUMBIA, Md., Oct. 19 /PRNewswire-FirstCall/ -- Celsion Corporation (Nasdaq: CLSN) announced today that two abstracts on the ThermoDox® High Intensity Focused Ultrasound (HIFU) development program have been delivered via oral presentation at the MR-guided Focused Ultrasound 2010 2nd International Symposium.  The abstracts provide strong proof of concept, as well as the rationale and support for future clinical studies, which will combine ThermoDox with MR-guided HIFU for cancer indications.  The symposium is being held October 17-20, 2010 at the Westfields Marriott in Dulles, VA .  

The first abstract, titled "MR-guided High Intensity Focused Ultrasound Enhances Targeted Drug Delivery of Low Temperature Sensitive Liposomes in a Rabbit Vx2 Tumor Model," is authored by Ashish Ranjan from the National Institutes of Health, Bethesda, MD, USA.  The second abstract, titled "Thermally-mediated Localized Drug Release Using MRI-Controlled Focused Ultrasound Hyperthermia," is authored by Robert Staruch from Sunnybrook Health Sciences Centre and University of Toronto, Canada.  Additional co-authors from the two studies are from Duke University, University of Helsinki, Finland, and Philips Healthcare.  The abstracts are available on the company's website site at www.celsion.com.  

"We are delighted to expand our HIFU program to leading oncology research centers in the US, Canada and Europe," said Michael H. Tardugno, Celsion's President and Chief Executive Officer. "We hope to make a seamless transition to clinical studies in these and additional countries based on the preclinical data that has been developed through our joint research agreement with Philips Healthcare.  Celsion and Philips are now well positioned to submit our clinical program for FDA review. Assuming we have agreement, we expect
'/>"/>

SOURCE Celsion Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Monitoring Committee Unanimously Recommends Continuation of Celsions Phase III ThermoDox® HEAT Study to Treat Primary Liver Cancer
2. Celsion Receives SBIR Grant To Expand Its Technology Platform
3. Celsion Receives Fast Track Designation for ThermoDox® Development Program to Treat Primary Liver Cancer
4. Celsion Announces CFO Departure
5. Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
6. Sysmex America Announces Amerinet Hematology Contract
7. iGPS Announces iGPS bios™, a New Pallet Rental Service Designed Exclusively for the Pharmaceutical and Life Sciences Industries
8. Accium BioSciences Announces $99 Sample Pricing for Its Accelerator Mass Spectrometry (AMS) Measurement Service
9. Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line
10. Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study
11. CoAxia Announces Results of SENTIS Ischemic Stroke Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 The National Necrotizing Fasciitis Foundation (NNFF) ... has been successfully treated for a life threatening form of ... R. Gauto , Medical Director of Inpatient Wound Care and ... in Rancho Mirage, California . ... John Crew at Seton Hospital in ...
(Date:8/20/2014)... -- Research and Markets has announced ... Care and Closure Market (Types, Applications, End User ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation ... their offering. The new report ... (types, applications, end user and geography) - Size, ...
(Date:8/20/2014)... ANN ARBOR, Mich. and ... a non-profit corporation established to bring cutting-edge next-generation ... trials to cancer patients, today announced a collaboration ... molecular capabilities to characterize patient tissue samples from ... be sensitive or resistant to TESARO,s TSR-011.  This may ...
Breaking Medicine Technology:Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 3Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 4Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 5Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 6Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2
... , , , , TEL ... - StemEx Study is Enrolling Patients at Cord Blood Transplant Centers in,the U.S., ... , Elbit Imaging Ltd. (NASDAQ: EMITF ) ("Elbit" ... Cell Ltd. ("Gamida Cell") through the Gamida-Teva Joint Venture (JV),announced today that the ...
... , , SAN DIEGO , ... a leading, global medical device company, today reported results from continuing ... 2009 . , "We continued to execute well during our ... Schlotterbeck , chairman and CEO of CareFusion. "Hospital capital spending made ...
Cached Medicine Technology:Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 2Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 3Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 4Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 5CareFusion Reports Second Quarter Results 2CareFusion Reports Second Quarter Results 3CareFusion Reports Second Quarter Results 4CareFusion Reports Second Quarter Results 5CareFusion Reports Second Quarter Results 6CareFusion Reports Second Quarter Results 7CareFusion Reports Second Quarter Results 8CareFusion Reports Second Quarter Results 9CareFusion Reports Second Quarter Results 10CareFusion Reports Second Quarter Results 11CareFusion Reports Second Quarter Results 12CareFusion Reports Second Quarter Results 13CareFusion Reports Second Quarter Results 14CareFusion Reports Second Quarter Results 15CareFusion Reports Second Quarter Results 16CareFusion Reports Second Quarter Results 17CareFusion Reports Second Quarter Results 18
(Date:8/20/2014)... By Dennis Thompson ... -- A new experimental drug has saved a group of ... of Ebola virus that kills up to 90 percent of ... monkeys infected with lethal doses of Marburg virus, even when ... study published Aug. 20 in the journal Science Translational ...
(Date:8/20/2014)... Bottom Line: Less than 42 percent of women ... and the factors associated with foregoing reconstruction included ... being older. , Author: Monica Morrow, M.D., of ... and colleagues. , Background: The Women,s Health and ... for breast reconstruction following a mastectomy. Still, most ...
(Date:8/20/2014)... study of chronic users of codeine-containing cough syrups ... brain white matter and associates these changes with ... used diffusuion tensor imaging (DTI) (an MR imaging ... white matter integrity of chronic CCS users. Deficits ... including the inferior fronto-occipital fasciculus, which other studies ...
(Date:8/20/2014)... August 20, 2014 Hundreds of Mirena ... of women who were allegedly injured due to spontaneous ... New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP ... August 15, 2014, the Court has established procedures regarding ... lawsuits that are part of the proceeding’s initial disposition ...
(Date:8/20/2014)... Gray HealthDay Reporter WEDNESDAY, ... rare, colds, flu and other minor infections might trigger a ... children, a new study suggests. Just five out of ... States, said Dr. Heather Fullerton, lead author of the study ... of California, San Francisco Benioff Children,s Hospital. "It seems infections ...
Breaking Medicine News(10 mins):Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 2Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 3Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 4Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3
... DETROIT, March 31 Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: ... that all tablets of Caraco brand Digoxin, USP, 0.125 mg, ... 2009, which are not expired and are within the expiration ... consumer level. The tablets are being recalled because they may ...
... The following is a statement from Jeff Levi, PhD, Executive ... is the latest reminder of how vulnerable our food safety ... set up to respond to many modern threats to our ... and understaffed. It is encouraging that this response was so ...
... office, being advised to do what you dread exercise. ... you should exercise but probably won,t. Now imagine that ... You read that right. Eye exercises are used to treat ... clinical associate professor at the University of Houston,s College of ...
... worse with newer scheduling option, study finds , , ... same-day medical scheduling to manage their care fared no ... compared with those who made their doctor,s appointments in ... With on-demand, or open-access, scheduling, doctors, offices give patients ...
... Nephros, Inc. (OTC Bulletin Board: NEPH) announced today financial results for ... , ... Concluded pivotal U.S. clinical trial for the ... , Appointed James Scibetta Chairman ...
... Unexpected Financial, Health, and Security Risks in Exotic Locales , ... ... who continue travel spending in a down economy should prepare for ... saved on their bargain vacation. Old and new destinations offering steep ...
Cached Medicine News:Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces a Nationwide Voluntary Recall of All Lots of Digoxin Tablets Due to Size Variability 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces a Nationwide Voluntary Recall of All Lots of Digoxin Tablets Due to Size Variability 3Health News:Trust for America's Health on the Recall of Certain Pistachios and the U.S. Food Safety System 2Health News:Eye exercises help patients work out vision problems, UH optometrist says 2Health News:Eye exercises help patients work out vision problems, UH optometrist says 3Health News:For Diabetics, On-Demand Care May Not Help 2Health News:Nephros Reports 2008 Fourth Quarter and Full Year Financial Results 2Health News:Nephros Reports 2008 Fourth Quarter and Full Year Financial Results 3Health News:Nephros Reports 2008 Fourth Quarter and Full Year Financial Results 4Health News:Nephros Reports 2008 Fourth Quarter and Full Year Financial Results 5Health News:Nephros Reports 2008 Fourth Quarter and Full Year Financial Results 6Health News:Nephros Reports 2008 Fourth Quarter and Full Year Financial Results 7Health News:Don't Sacrifice Your Well-being in a Discount Destination 2Health News:Don't Sacrifice Your Well-being in a Discount Destination 3
... Biotech Captia™ Legionella pneumophila IgG/IgM ... intended for the qualitative detection ... IgM) to Legionella pneumophila (Legionella) ... patients with clinical suspicion of ...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
... approach to treatment that makes ... range to 25 cm H2O, ... patients with severe OSA. BiPAP ... humidification and built-in Encore® Pro ...
... HDL into large, intermediate and small particles ... The test procedure is simple and can ... A color coded profile is generated where ... Lipoprint HDL Kit contains all reagents necessary ...
Medicine Products: